Geron Future Growth
Future criteria checks 5/6
Geron is forecast to grow earnings and revenue by 72.4% and 51.8% per annum respectively while EPS is expected to grow by 72.4% per annum.
Key information
72.4%
Earnings growth rate
72.4%
EPS growth rate
Biotechs earnings growth | 42.4% |
Revenue growth rate | 51.8% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 562 | 116 | 57 | 100 | 7 |
12/31/2025 | 301 | -50 | -93 | -85 | 9 |
12/31/2024 | 89 | -167 | -115 | -198 | 9 |
9/30/2024 | 29 | -201 | -216 | -216 | N/A |
6/30/2024 | 1 | -220 | -209 | -208 | N/A |
3/31/2024 | 1 | -201 | -185 | -184 | N/A |
12/31/2023 | 0 | -184 | -169 | -168 | N/A |
9/30/2023 | 0 | -175 | -163 | -162 | N/A |
6/30/2023 | 0 | -171 | -142 | -141 | N/A |
3/31/2023 | 0 | -150 | -141 | -140 | N/A |
12/31/2022 | 1 | -142 | -128 | -127 | N/A |
9/30/2022 | 2 | -131 | -115 | -114 | N/A |
6/30/2022 | 1 | -117 | -108 | -108 | N/A |
3/31/2022 | 1 | -118 | -97 | -97 | N/A |
12/31/2021 | 1 | -116 | -96 | -96 | N/A |
9/30/2021 | 0 | -108 | -86 | -86 | N/A |
6/30/2021 | 0 | -101 | -79 | -79 | N/A |
3/31/2021 | 0 | -87 | -73 | -73 | N/A |
12/31/2020 | 0 | -76 | -67 | -67 | N/A |
9/30/2020 | 0 | -81 | -65 | -64 | N/A |
6/30/2020 | 0 | -76 | -62 | -61 | N/A |
3/31/2020 | 0 | -75 | -58 | -57 | N/A |
12/31/2019 | 0 | -69 | -44 | -44 | N/A |
9/30/2019 | 1 | -47 | -37 | -36 | N/A |
6/30/2019 | 1 | -37 | -31 | -31 | N/A |
3/31/2019 | 1 | -30 | -26 | -26 | N/A |
12/31/2018 | 1 | -27 | -21 | -21 | N/A |
9/30/2018 | 1 | -27 | -22 | -22 | N/A |
6/30/2018 | 1 | -28 | N/A | -21 | N/A |
3/31/2018 | 1 | -28 | N/A | -21 | N/A |
12/31/2017 | 1 | -28 | N/A | -21 | N/A |
9/30/2017 | 1 | -29 | N/A | -17 | N/A |
6/30/2017 | 6 | -26 | N/A | -19 | N/A |
3/31/2017 | 6 | -28 | N/A | -20 | N/A |
12/31/2016 | 6 | -30 | N/A | -18 | N/A |
9/30/2016 | 6 | -30 | N/A | -23 | N/A |
6/30/2016 | 37 | 1 | N/A | -21 | N/A |
3/31/2016 | 37 | 1 | N/A | -22 | N/A |
12/31/2015 | 36 | 0 | N/A | -24 | N/A |
9/30/2015 | 36 | 0 | N/A | 10 | N/A |
6/30/2015 | 1 | -37 | N/A | 10 | N/A |
3/31/2015 | 1 | -37 | N/A | 11 | N/A |
12/31/2014 | 1 | -36 | N/A | 9 | N/A |
9/30/2014 | 1 | -36 | N/A | -26 | N/A |
6/30/2014 | 1 | -35 | N/A | -27 | N/A |
3/31/2014 | 1 | -35 | N/A | -30 | N/A |
12/31/2013 | 1 | -38 | N/A | -37 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GON is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: GON is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: GON is expected to become profitable in the next 3 years.
Revenue vs Market: GON's revenue (51.8% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: GON's revenue (51.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GON's Return on Equity is forecast to be high in 3 years time